Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
KAZIA MARKS DIPG AWARENESS DAY; NEW PRECLINICAL DATA IN DIPG TO BE PRESENTED AT ISPNO CONFERENCE 2022-05-17 20:00
GeneQuantum Healthcare's Two Next Generation Bioconjugate Drugs, GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia 2022-05-16 09:00
Kintor Pharma Included in MSCI China Index 2022-05-15 18:28
Dizal Announces New Data from the Phase I/II Study of Golidocitnib in Refractory or Relapsed Peripheral T Cell Lymphoma Selected for Oral Presentation at 2022 EHA Annual Meeting 2022-05-13 19:09
Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria 2022-05-12 22:43
Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-targeting CAR-T GC012F in RRMM and B-NHL and CD19/CD7 Dual-directed Allogeneic CAR-T GC502 in B-ALL at EHA2022 Congress 2022-05-12 22:01
BIORCHESTRA Participated in Formulation and Delivery 2022-05-12 21:00
Formosa Pharmaceuticals and AimMax Therapeutics Announce Successful Top-Line Results from CPN-301 for the Treatment of Inflammation and Pain after Cataract Surgery 2022-05-12 20:00
A novel universal antiviral drug introduced in Korea 2022-05-12 18:19
Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial 2022-05-12 08:00
Asia's first molecular diagnostics company for women, INEX Innovate receives European CE-IVD Certification for its OvaCis(R) Rapid Test to detect cancer in ovarian cysts. 2022-05-11 22:00
PharmAbcine to participate in Jefferies Global Healthcare Conference and BIO International Convention 2022-05-11 20:00
Bridge Biotherapeutics to Announce Updated Data from its Phase 1 Study of BBT-176 in Advanced Non-Small Cell Lung Cancer in an Oral Presentation at IASLC 2022 World Conference on Lung Cancer 2022-05-10 21:00
Nature Medicine Publishes Results from an Investigator-Initiated Trial of CARsgen's CT041 Claudin18.2 CAR T Cells in Gastrointestinal Cancers 2022-05-10 20:50
Harbour BioMed to Present the Latest Progress of Next-Generation Anti-CTLA-4 Antibody HBM4003 at 2022 ASCO Annual Meeting 2022-05-10 16:54
AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau 2022-05-10 09:00
Formus Labs, a Pioneering Developer of Orthopedic Surgery Planning Technology, Hires Ex-Johnson & Johnson Executive, Polly Teevan, To Lead Global Commercial Strategy 2022-05-10 03:00
iNtRON Biotechnology, Inc., Launches New Website 2022-05-09 21:00
AskGene Limited Announces Completion of USD 20 Million Series A Financing Led by Qiming Venture Partners and TF Capital 2022-05-09 11:37
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers 2022-05-09 08:04
1 128 129 130 131 132 432